Skip to main content

Cancer, General clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for
  • A Study of the Experimental Prevena™ device (Incisional Negative Pressure Wound Therapy) for Soft Tissue Sarcoma Wounds

    open to eligible people ages 18 years and up

    This is a study comparing two methods of dressing a post operative wound that are currently in practice. One method is a traditional dry gauze dressing. The other method is using a negative pressure dressing that provides gentle suction on the wound. The investigators will attempt to determine how well the use of post-operative negative pressure dressing reduces wound healing problems in patients who have surgery after radiation for a sarcoma in the thigh or leg.

    Charleston, South Carolina

  • Experimental Immunotherapy with BMS-986299 With or Without Nivolumab and Ipilimumab For Advanced Solid Cancer

    open to eligible people ages 18 years and up

    The purpose of this study is to determine whether BMS-986299 both by itself and in combination with Nivolumab and Ipilimumab is safe and tolerable in the treatment of advanced solid tumors. In addition, the ability of study drugs to stimulate an immune response against cancer will be investigated.

    Sacramento, California and other locations

Last updated: